Maynard Um
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) Remains a Top 2016 Pick at Mizuho
-
-
-
-
-
-
-
Notice to Long-Term Shareholders of Amylyx Pharmaceuticals, Inc. (AMLX): Grabar Law Office is Investigating Claims on Your Behalf as Securities Fraud Class Action Survives Motion to Dismiss
-
-
-
-
-
-
-
Goldman Sachs Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
-
-
-
-
-
-
-
Guggenheim Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q1 EPS by 20c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Amylyx Pharmaceuticals inc. (AMLX)
-
415,792 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

